LSTA: Lisata Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 22.43
Enterprise Value ($M) -0.42
Book Value ($M) 47.89
Book Value / Share 5.77
Price / Book 0.47
NCAV ($M) 47.12
NCAV / Share 5.67
Price / NCAV 0.48

Profitability (mra)
Return on Invested Capital (ROIC) -0.43
Return on Assets (ROA) -0.31
Return on Equity (ROE) -0.34

Liquidity (mrq)
Quick Ratio 8.18
Current Ratio 8.18

Balance Sheet (mrq) ($M)
Current Assets 53.92
Assets 54.69
Liabilities 6.80
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -25.71
Net Income -20.84
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Basic And Diluted Since Acquisition n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -20.03
Cash from Investing 10.10
Cash from Financing 0.39

(click for more detail)
Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-02 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-05-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-30 873 9,463 9.23
2024-04-29 1,277 314 406.69
2024-04-26 274 1,046 26.20
2024-04-25 1,896 1,076 176.21

(click for more detail)

Similar Companies
LPTX – Leap Therapeutics, Inc. LQDA – Liquidia Corporation
LSDI – Lucy Scientific Discovery Inc. LTRN – Lantern Pharma Inc.
MBIO – Mustang Bio, Inc.


Financial data and stock pages provided by
Fintel.io